iiinova — where your digital self keeps evolving

As global health leaders ready themselves for this year’s World Health Summit Health Summit in Berlin, CEPI invites you to join its official panel discussion, From Crisis Response to Resilience: Innovating for Health Security Beyond Borders. Register: www.worldhealthsummit.org/sessions/034...

001

CEPI @cepi.net · 29/09/2026

New funding: The @bioprevail.bsky.social x CEPI Biosecurity Innovation Challenge is seeking practical biosafety and biosecurity innovations to strengthen vaccine R&D and manufacturing during epidemic and pandemic responses, supporting CEPI’s 100 Days Mission: bioprevail.org/challenge/bi...

111

CEPI @cepi.net · 21/09/2026

🔉 Major new funding for CEPI announced today. Ethiopia, Norway and the UK have pledged a combined US$240 million to support CEPI’s five-year plan to transform the world’s ability to prevent and respond to future epidemic and pandemic threats. cepi.net/ethiopia-nor...

163

CEPI @cepi.net · 03/09/2026

As global leaders gather for the UN General Assembly High-Level Meeting on Pandemic Prevention, Preparedness and Response, CEPI invites you to join its flagship side event: Building Crisis-Ready Coalitions: From Fragmentation to Readiness. Register now: web-eur.cvent.com/event/44c8f5...

110

CEPI @cepi.net · 27/08/2026

We've announced a new US$16.5 million partnership with African biopharmaceutical company Minapharm Group to develop their Bundibugyo vaccine candidate. The Bundibugyo epidemic in the DRC is the fastest-growing and second-largest Ebola outbreak on record: cepi.net/african-bund...

012

CEPI @cepi.net · 14/08/2026

We’re delighted to announce that the CEPI Board has appointed Professor Ibrahim Abubakar as CEPI’s next Chief Executive Officer. cepi.net/cepi-board-a...

110

CEPI @cepi.net · 04/08/2026

The first participant has been dosed in a CEPI-backed Phase 1 trial of Moderna's investigational vaccine against Bundibugyo virus, marking rapid progress in the global effort to combat the deadly Ebola outbreak in DRC. Read more: cepi.net/modernas-bun...

A healthy adult participant, Susan Murray, receives the first dose in Moderna’s Phase 1 clinical trial in Canada evaluating mRNA-1469, an investigational vaccine candidate against Bundibugyo ebolavirus, in Truro, Nova Scotia, on August 3, 2026

114

CEPI @cepi.net · 03/08/2026

The Bundibugyo Ebola epidemic in the Democratic Republic of the Congo has passed a tragic milestone. Just 11 weeks after it was declared, the outbreak has reached 3,748 confirmed cases, making it the second-largest Ebola outbreak in history and the fastest-growing ever recorded.

174

CEPI @cepi.net · 27/07/2026

A powerful affirmation from Institut Pasteur de Dakar CEO Dr. Ibrahima Socé Fall, one of CEPI's key manufacturing partners, on the need for an organisation like CEPI and why continued investment in CEPI 3.0 is critical for our collective global health security ⬇️

110

CEPI @cepi.net · 24/07/2026

The first volunteer has been vaccinated with the @ox.ac.uk's Bundibugyo ebolavirus vaccine candidate in a CEPI-backed clinical trial as efforts ramp up to contain a fast-spreading and deadly outbreak affecting the Democratic Republic of the Congo. Read more: www.ox.ac.uk/news/2026-07...

052

CEPI @cepi.net · 08/07/2026

CEPI has recently published its 2025 Annual Progress Report – a timely reflection of a year that reinforced why epidemic and pandemic preparedness is more important than ever. Read it here: static.cepi.net/downloads/20...

161

CEPI @cepi.net · 01/06/2026

With no licensed vaccines available for Bundibugyo virus and none in clinical development, CEPI's action reflects the critical urgency to produce tools to help curtail the outbreak.

100

CEPI @cepi.net · 01/06/2026

The outbreak, affecting the Democratic Republic of the Congo and Uganda, has been classified as a public health emergency by both the Africa CDC and the @who.int. Just weeks since it was declared, it is already the third largest Filovirus outbreak in history.

100

CEPI @cepi.net · 21/05/2026

The next pandemic could begin anywhere, at any moment. And the risk of a deadly outbreak is only rising. But it doesn’t have to be that way. CEPI 3.0 is our plan to move the world from reactive response to proactive protection.

192

CEPI @cepi.net · 19/05/2026

Europe is reinforcing its commitment to a world protected from epidemic and pandemic threats as current outbreaks underscore the persistent risk posed by infectious diseases. Today at #WHA79, the @ec.europa.eu announced €73.7 million commitment to CEPI for 2026 and 2027. 🇪🇺 More: bit.ly/4dxBcdE

100

CEPI @cepi.net · 19/05/2026

Singapore is strengthening global defences against future epidemic and pandemic threats. Today at #WHA79, Singapore pledged US$12 million to support our CEPI 3.0 strategy—a powerful signal of leadership from a global innovation hub. 🇸🇬 More: bit.ly/4dxBcdE

110

CEPI @cepi.net · 19/05/2026

As CEPI CEO Dr Richard Hatchett noted today, these investments help strengthen the world’s disease defences at a time when the gap between the threats we face and our readiness to meet them remains dangerously wide.

111

CEPI @cepi.net · 19/05/2026

LIVE: watch our official #WHA79 side event entitled: “From Outbreak Response to System Readiness: Building the Global and Regional Capabilities to Stop Pandemic Threats in 100 Days” Click the link to watch in real time 📺 bit.ly/4eReCPm

020

CEPI @cepi.net · 08/05/2026

We sat down with CEPI’s Director of R&D programmes, Dr Mandeep Singh Dhingra, MD, for the first instalment of our new CEPI 3.0 explainer series to learn more about the viral family approach and its role in the CEPI 3.0 Strategy: cepi.net/cepi-30-expl...

030

CEPI @cepi.net · 29/04/2026

Last week, the CEPI team joined health leaders at the 27th Assembly of ECOWAS Health Ministers in Freetown, Sierra Leone, to share progress in the fight against Lassa fever and CEPI’s plans to make the 100 Days Mission a reality. sciencenigeria.com/lassa-vaccin...

000

CEPI @cepi.net · 10/04/2026

"The 100 Days Mission reflects our shared commitment to deliver faster, safer and more effective preparedness and response for all countries." A powerful message of support for CEPI 3.0 and the 100 Days Mission from Indonesia's Minister of Health, Budi Sadikin ⬇️

131

CEPI @cepi.net · 27/03/2026

📣Positive topline results from a CEPI-supported study of Bavarian Nordic's Mpox vaccine in 2-to-11-year-olds have been submitted to the European Medicines Agency, paving the way for the jab to be approved for use in younger age groups: www.bavarian-nordic.com/investor/new...

001

CEPI @cepi.net · 12/03/2026

CEPI strengthens global biosecurity with eight new partnerships ⬇️ The partnerships will help advance our biosecurity work. Selected through a competitive Request for Proposals, these organisations are global leaders in training, policy, laboratory infrastructure, and biorisk management.

132

CEPI @cepi.net · 11/03/2026

"The 100 Days Mission is a game-changer" - H.E Dr Jean Kaseya, Director General, Africa CDC. In this supportive statement from Africa CDC, Dr Kaseya explains how CEPI's 100 Days Mission is helping the continent to #SecureTheFuture against the threat of epidemics and pandemics.

110

CEPI @cepi.net · 02/03/2026

"In less than 10 years, CEPI has helped to redefine how the world develops vaccines for emerging infectious diseases, shifting from reactive crisis response to collaborative preparedness." - Dr Tedros Adhanom Ghebreyesus. A powerful endorsement of CEPI 3.0 from our @who.int partners.

000

CEPI @cepi.net · 18/02/2026

As we build momentum for CEPI 3.0 (2027–2031), we’re sharing messages from across our Coalition, showing why investment is key to securing the future from epidemic and pandemic threats. Below, Gavi CEO Dr Sania Nishtar shares her support and how our organisations collaborate to protect everyone.

020

CEPI @cepi.net · 13/02/2026

“We invest in CEPI because it makes Norway safer, and it makes the world safer” — Jonas Gahr Støre, Prime Minister of Norway. In a new message marking the launch of our CEPI 3.0 Investment Case, Norway’s Prime Minister underscores why sustained investment in CEPI matters, nationally and globally.

111

CEPI @cepi.net · 13/02/2026

... and support global networks that are ready to respond to future threats swiftly and equitably, whenever and wherever they emerge.

100

CEPI @cepi.net · 03/02/2026

Samsung Biologics becomes the latest organisation to join CEPI's Vaccine Manufacturing Facility Network (VMFN) -- a globally distributed manufacturing ecosystem designed to enable rapid and equitable access to vaccines in future pandemics. More: cepi.net/cepi-and-sam...

110

CEPI @cepi.net · 27/01/2026

The 100 Days Mission 5th Implementation Report is now available. The report, produced by @ippsecretariat.org, reflects a pivotal year for pandemic preparedness, reviewing recent progress and setting out priorities for 2026. 📘 bit.ly/100dm-5th-re...

021

CEPI @cepi.net · 12/12/2025

CEPI is backing a second $198,000 project with GENSPEED Biotech to speed up vaccine quality testing. The rapid, automated assay can detect residual proteins in ~20 minutes—far faster than today’s 3-hour methods.

100

CEPI @cepi.net · 01/12/2025

Last month, CEPI had the pleasure of welcoming Marjolijn Sonnema, Vice Minister of Health of the Netherlands, to The Aurum Institute in Johannesburg.

100

CEPI @cepi.net · 20/11/2025

Join WAHO, CEPI & partners for a webinar launching the Lassa Fever Research Agenda & open-access Repository—key tools to guide research, inform policy, and support timely, equitable vaccine introduction. 📅 25 Nov | 🕛 12:00 GMT 🔗 Register: bit.ly/4i8pYxT

011

CEPI @cepi.net · 19/11/2025

A new CEPI-funded initiative with LumaCyte and IDT Biologika aims to overcome a major hurdle in vaccine manufacturing: the slow, complex process of potency testing.

111

CEPI @cepi.net · 13/11/2025

Sterility testing — ensuring vaccine batches are free from microbial contamination — can take up to a month. With new CEPI funding of up to $199,238, USA-based CBio will develop a rapid sterility testing system based on its cellPhoresis™ technology.

100

CEPI @cepi.net · 13/11/2025

The West African Health Organization(WAHO), with support from CEPI and other partners, have launched the first-ever Lassa Fever Vaccine Policy Research Agenda. Read in full: bit.ly/4nTNVdO

121

CEPI @cepi.net · 22/10/2025

New CEPI-funded project will harness innovative microbial testing methods to accelerate vaccine sterility testing from weeks to days. CEPI funding of up to US$197,280 will support Swedish-based Symcel to develop a rapid sterility testing method for vaccines using its calScreener+ platform.

221

CEPI @cepi.net · 21/10/2025

Last month, Health Emergencies Response Canada (HERC) and CEPI co-chaired a roundtable in Ottawa with organisations funding and delivering R&D for diagnostics, vaccines and therapeutics for epidemic and pandemic threats.

111

CEPI @cepi.net · 17/10/2025

Following the recent framework agreement with Fondation Mérieux, CEPI is also partnering with the @ukhsa.bsky.social to support biosecurity capacity strengthening with national public health institutions and universities involved in epidemic preparedness and infectious disease research across DRC.

120

CEPI @cepi.net · 17/10/2025

New CEPI-funded project will partner with Austria’s GENSPEED Biotech to repurpose its GENSPEED R2 device to create a fast, fully automated quality control test for detecting residual HEK293 host cell proteins, a critical step in ensuring vaccine safety and consistency.

100

CEPI @cepi.net · 12/10/2025

As one of CEPI’s longest-standing and largest funders, Germany’s renewed commitment recognises that global cooperation, scientific excellence and solidarity are our best defences against future health crises.

110

CEPI @cepi.net · 12/10/2025

📢 Germany reaffirms its global health leadership with a EUR 100M pledge to CEPI. This continued support helps power CEPI’s mission to take many of the world’s most dangerous epidemic and pandemic threats off the table for the benefit of all. cepi.net/bmftr-boosts...

130

CEPI @cepi.net · 12/10/2025

Deutschland ist Gründungsmitglied und einer der größten Geldgeber von CEPI. Mit seiner erneuten Unterstützung wird Deutschland dazu beitragen, die Mission von CEPI voranzutreiben, viele der gefährlichsten Epidemien und Pandemien weltweit zum Wohle aller zu bekämpfen.

100

CEPI @cepi.net · 12/10/2025

📢 Die Bundesrepublik Deutschland hat ihre weltweite Vorreiterrolle im Gesundheitsbereich mit einer erneuten Zusage in Höhe von 100 Millionen Euro für CEPI bekräftigt.

200

CEPI @cepi.net · 03/10/2025

How can #AI accelerate vaccine development and strengthen pandemic preparedness? This was the question explored last week on the sidelines of #UNGA80 as CEPI and @foreignpolicy.com brought together global health leaders, researchers, policymakers, and technologists.

120

CEPI @cepi.net · 26/09/2025

CEPI is partnering with UKHSA & Fondation Mérieux through two new framework agreements aimed at strengthening biosecurity capacities in the DRC, supporting CEPI’s existing R&D partners in the region. 📸 CEPI's Andrew Hebbeler signing the new partnership with Fondation Mérieux on sidelines of UNGA.

010

CEPI @cepi.net · 23/09/2025

📺💡A new BBC Horizon documentary, ‘Disease X: Hunting the next pandemic’ delves into the potential deadly threat of a future unknown disease that could spread globally – and the possible culprit viral families it could come from, such as a virus related to the deadly Nipah or influenza strains (1/3)

1135

CEPI @cepi.net · 16/09/2025

📣 Four global health and science experts, widely recognised for their contributions in tackling deadly infectious disease threats, have been appointed to key governance positions at CEPI. ▶️ cepi.net/top-health-a...

031

CEPI @cepi.net · 12/09/2025

Did you know the next pandemic is likely to emerge from one of 25 or so viral families? Learning as much as possible about them now & building a library of knowledge is helping scientists get ahead of this threat. Discover the families in CEPI's The Viral Most Wanted ➡️ cepi.net/viral-most-w...

041

CEPI @cepi.net · 11/09/2025

📣We're providing up to $10.4 million to work with international partners and gather real-world insights into the use of the Lc16m8 vaccine in protecting against mpox in the DRC. The research could help tackle the ongoing mpox outbreak which remains a continental emergency👉 cepi.net/new-mpox-vac...

042